Urinary retention rates after intravesical onabotulinumtoxinA injection for idiopathic overactive bladder in clinical practice and predictors of this outcome

Publisher： John Wiley & Sons Inc

E-ISSN： 1520-6777|34|7|675-678

ISSN： 0733-2467

Source： NEUROUROLOGY AND URODYNAMICS, Vol.34, Iss.7, 2015-09, pp. : 675-678

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy and safety of onabotulinumtoxinA injection in patients with refractory overactive bladder: First multicentric study in Turkish population

By  

NEUROUROLOGY AND URODYNAMICS, Vol. 37, Iss. 1, 2018-01 ,pp. : 263-268

John Wiley & Sons Inc

Access to resources Recommend Favorite

Botulinum toxin (OnabotulinumtoxinA) in the male non‐neurogenic overactive bladder: clinical and quality of life outcomes

By  

BJU INTERNATIONAL, Vol. 116, Iss. S3, 2015-10 ,pp. : 61-65

John Wiley & Sons Inc

Access to resources Recommend Favorite

MicroRNAs as potential biomarkers to predict the risk of urinary retention following intradetrusor onabotulinumtoxin‐A injection

By  

NEUROUROLOGY AND URODYNAMICS, Vol. 37, Iss. 1, 2018-01 ,pp. : 99-105

John Wiley & Sons Inc

Access to resources Recommend Favorite

Patient experience and satisfaction with Onabotulinumtoxin A for refractory overactive bladder

By  

BJU INTERNATIONAL, Vol. 116, Iss. 3, 2015-09 ,pp. : 443-449

John Wiley & Sons Inc

Access to resources Recommend Favorite

Is it possible to make cross-study comparisons of urinary continence rates in patients with overactive bladder?

By Staskin David R.   Wein Alan  

Current Medical Research and Opinion, Vol. 21, Iss. 6, 2005-06 ,pp. : 835-838

Informa Healthcare

Access to resources Recommend Favorite